معرفی
Robert Riener is a Full Professor at the Department of Health Sciences and Technology (D-HEST), ETH Zurich, and holds a professorship in medicine at the Balgrist University Hospital (University of Zurich). His academic journey includes a Dipl.-Ing. and Dr. degree from TU München (1993, 1997), followed by postdoctoral work at Politecnico di Milano and habilitation in Biomechatronics. He has led D-HEST (2016–2018) and pioneered robots for rehabilitation and sports. His research focuses on human biomechanics, virtual reality, sleep robotics, and rehabilitation robotics, with over 500 publications and patents. Riener initiated the Cybathlon, a championship for athletes using assistive technology, recognized with multiple awards including the European Excellence Award and IEEE RAS/EMBS Key Innovator Award.
His education includes studies at TU München and the University of Maryland, followed by a career at ETH Zurich since 2003. Riener’s work bridges engineering and medicine, addressing neuroprosthetics, robotic rehabilitation systems (e.g., ARMin), and sleep-related robotics. Awards include the Swiss Technology Award, humanTech Innovation Prize, and AAAS Leshner Fellowship. His current projects involve robotic beds for sleep disorders, wearable exosuits, and gait assistance technologies.
Key research trends in his articles include advancements in robotic control systems, wearable exoskeletons, and data-driven approaches to rehabilitation. His work emphasizes clinical validation and adaptive human-robot interfaces. Riener’s contributions span from fundamental biomechanical studies to large-scale implementations like Cybathlon, reflecting interdisciplinary innovation.
Notable awards include the euRobotics Technology Transfer Awards (2011, 2012, 2021), IEEE Best Paper Awards, and an honorary doctorate from the University of Basel. His grants and collaborations involve EU-funded projects and industry partnerships. Riener heads labs focused on rehabilitation robotics, biomechanics, and sleep technology, fostering international collaborations and translating research into clinical applications.
